drugset / Trial / NCT05107011
Phase I/II Clinical Trial of LBL-015 for Injection
Phase 1/2
Completed
25 enrolled
Nanjing Leads Biolabs Co.,Ltd
Henan Cancer Hospital · collabHunan Cancer Hospital · collabShandong Cancer Hospital and Institute · collabShanghai East Hospital · collabThe First Affiliated Hospital of Bengbu Medical University · collabThe First Affiliated Hospital of Nanchang University · collab
NaSingle-groupOpen-labelTreatment
Summary
A Multicenter, Open-label, Phase I/II Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Efficacy of LBL-015 in Patients With Advanced Malignant Tumors.
Timeline
- Start
- 2021-11-08
- Primary completion
- 2023-12-05
- Completion
- 2023-12-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | LBL-015 | Unknown | — | Intravenous |